Vertos Medical completed a US $28MM financing round. Funds will support commercialization of the mild® outpatient procedure for the minimally invasive treatment of stenosis, including surgeon education. Strong demand for the procedure follows its receipt of broad coverage from the Centers for Medicare & Medicaid Services, announced in 1Q17.
MVM Life Science Partners led the round, with existing investors Leerink Revelation Partners, Pitango Venture Capital, ONSET Ventures and Aweida Venture Partners.
The mild procedure has been performed on >20,000 patients and has CE Mark approval in the EU.
Vertos Medical completed a US $28MM financing round. Funds will support commercialization of the mild® outpatient procedure for the minimally invasive treatment of stenosis, including surgeon education. Strong demand for the procedure follows its receipt of broad coverage from the Centers for Medicare & Medicaid Services, announced in...
Vertos Medical completed a US $28MM financing round. Funds will support commercialization of the mild® outpatient procedure for the minimally invasive treatment of stenosis, including surgeon education. Strong demand for the procedure follows its receipt of broad coverage from the Centers for Medicare & Medicaid Services, announced in 1Q17.
MVM Life Science Partners led the round, with existing investors Leerink Revelation Partners, Pitango Venture Capital, ONSET Ventures and Aweida Venture Partners.
The mild procedure has been performed on >20,000 patients and has CE Mark approval in the EU.
Copy to clipboard 
